Page 83 - AIDSBK23C
P. 83

Page 83


                       The immunologic categories for clinical classification of HIV infection in children is
               based on age-specific CD4 lymphocyte counts and the percent of total lymphocytes as follows:

                              Immunologic category 1:      No evidence of suppression
                              Immunologic category 2:      Evidence of moderate suppression
                              Immunologic category 3:      Severe suppression

                                                   Age of child

                              < 12 months                  1-5 years                   6-12 years
               Immunologic
               category
                              CD4 /µL         %            CD4 /µL         %           CD4 /µL          %

               1:             ≥1500         (≥25)          ≥1000         (≥ 25)        ≥500           (≥ 25)
               2:             750-1499      (15-24)        500-999       (15-24)       200-499         (15-24)
               3:             <750          (<15)          <500          (<15)         <200           (<15)


               Thus, the 1994 CDC classification system for HIV infection can be summarized as follows:

                              N = No signs or symptoms
                              A = Mild signs or symptoms
                              B = Moderate signs or symptoms
                              C = Severe signs or symptoms

                                                                      Clinical Categories
               Immunologic Categories                             N      A      B      C

               1.      No evidence of suppression                 N1     A1     B1     C1
               2.      Evidence of moderate suppression           N2     A2     B2     C2
               3.      Severe suppression                         N3     A3     B3     C3



               CRITERIA FOR PERSISTANT GENERALIZED LYMPHADENOPATHY

                       The original criteria for inclusion of patients into the condition of persistent generalized
               lymphadenopathy (PGL) are given below:

               *       Persistent generalized lymphadenopathy involving two or more extra inguinal sites
                       lasting  3 months or more
               *       Absence of an intercurrent disease or illness causing the lymphadenopathy
               *       Reactive pattern on tissue biopsy
   78   79   80   81   82   83   84   85   86   87   88